CareDx, Inc – NASDAQ:CDNA
CareDx stock price today
$11.58
-9.51
-45.09%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
CareDx stock price monthly change
+32.56%
month
CareDx stock price quarterly change
+32.56%
quarter
CareDx stock price yearly change
+66.06%
year
CareDx key metrics
Market Cap | 1.11B |
Enterprise value | 418.48M |
P/E | -6.05 |
EV/Sales | 1.30 |
EV/EBITDA | -7.41 |
Price/Sales | 1.45 |
Price/Book | 1.08 |
PEG ratio | 0.04 |
EPS | -3.42 |
Revenue | 275.11M |
EBITDA | -79.68M |
Income | -183.19M |
Revenue Q/Q | -6.74% |
Revenue Y/Y | -13.93% |
Profit margin | -23.81% |
Oper. margin | -24% |
Gross margin | 65.13% |
EBIT margin | -24% |
EBITDA margin | -28.97% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCareDx stock price history
CareDx stock forecast
CareDx financial statements
Average Price Target
$36.75
Potential upside: 217.35%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 70.30M | -24.95M | -35.49% |
|---|---|---|---|
| Sep 2023 | 67.19M | -23.48M | -34.95% |
| Dec 2023 | 65.56M | -118.09M | -180.11% |
| Mar 2024 | 72.04M | -16.65M | -23.12% |
| Jun 2023 | 514820000 | 109.60M | 21.29% |
|---|---|---|---|
| Sep 2023 | 501180000 | 107.04M | 21.36% |
| Dec 2023 | 484615000 | 223.28M | 46.08% |
| Mar 2024 | 452406000 | 196.18M | 43.36% |
| Jun 2023 | -499K | 15.34M | -1.56M |
|---|---|---|---|
| Sep 2023 | -10.17M | -1.49M | -25K |
| Dec 2023 | -8.38M | 41.36M | -26.87M |
| Mar 2024 | -15.31M | 27.66M | -1.27M |
CareDx alternative data
| Aug 2023 | 727 |
|---|---|
| Sep 2023 | 727 |
| Oct 2023 | 727 |
| Nov 2023 | 727 |
| Dec 2023 | 727 |
| Jan 2024 | 727 |
| Feb 2024 | 727 |
| Mar 2024 | 635 |
| Apr 2024 | 635 |
| May 2024 | 635 |
| Jun 2024 | 635 |
| Jul 2024 | 635 |
CareDx other data
100.00%
0.00%
of CDNA is owned by hedge funds
202
-18
56.31M
+2.28M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2024 | 0 | 130806 |
| Nov 2024 | 0 | 11757 |
| Dec 2024 | 0 | 1917 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | NOVACK JEFFREY ADAM officer: Secretary and General .. | Common Stock | 1,917 | $26 | $49,842 | ||
Option | MAAG PETER director | Common Stock | 5,000 | $12.24 | $61,200 | ||
Sale | MAAG PETER director | Common Stock | 5,000 | $25 | $125,000 | ||
Option | MAAG PETER director | Stock Option (right to buy) | 5,000 | $12.24 | $61,200 | ||
Sale | NOVACK JEFFREY ADAM officer: Secretary and General .. | Common Stock | 365 | $24 | $8,760 | ||
Sale | NOVACK JEFFREY ADAM officer: Secretary and General .. | Common Stock | 858 | $24 | $20,592 | ||
Sale | NOVACK JEFFREY ADAM officer: Secretary and General .. | Common Stock | 3,656 | $21.65 | $79,160 | ||
Sale | NOVACK JEFFREY ADAM officer: Secretary and General .. | Common Stock | 807 | $22 | $17,754 | ||
Sale | NOVACK JEFFREY ADAM officer: Secretary and General .. | Common Stock | 1,071 | $22 | $23,562 | ||
Option | BICKERSTAFF GEORGE director | Common Stock | 2,226 | $5.49 | $12,221 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 8 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Peter Maag Ph.D. (1967) Executive Director | $1,350,000 |
| Dr. Reginald Seeto (1972) Pres, Chief Executive Officer & Director | $989,040 |
Ms. Sasha King M.B.A. (1986) Chief Marketing Officer & Franchise Head of Kidney Transplant | $668,800 |
Mr. Marcel Konrad (1976) Senior Vice President of Fin. and Accounting & Corporation Controller | $437,530 |
Natera: Poised For A Great Future But I'd Wait For A Pullback
CareDx: Too Risky For Me
CareDx: Top Of My Shopping List For 2025
Exact Sciences Up 25% YTD: Here Is What To Expect In 2023
CareDx: What To Make Of The New Share Repurchase Program (Rating Upgrade)
Veracyte: Sustainable Rally Supported By Spectacular Execution In Q3
CareDx: Shaking Off First-Mover Disadvantage
CareDx: Best Near Cap-Gain Health Diagnostics Prospect Say Market Makers
CareDx: Short-Term Headwinds Will Pass, Longer-Term High Growth Investment Case Remains
-
What's the price of CareDx stock today?
One share of CareDx stock can currently be purchased for approximately $11.58.
-
When is CareDx's next earnings date?
Unfortunately, CareDx's (CDNA) next earnings date is currently unknown.
-
Does CareDx pay dividends?
No, CareDx does not pay dividends.
-
How much money does CareDx make?
CareDx has a market capitalization of 1.11B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 12.89% to 280.32M US dollars.
-
What is CareDx's stock symbol?
CareDx, Inc is traded on the NASDAQ under the ticker symbol "CDNA".
-
What is CareDx's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of CareDx?
Shares of CareDx can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are CareDx's key executives?
CareDx's management team includes the following people:
- Dr. Peter Maag Ph.D. Executive Director(age: 58, pay: $1,350,000)
- Dr. Reginald Seeto Pres, Chief Executive Officer & Director(age: 53, pay: $989,040)
- Ms. Sasha King M.B.A. Chief Marketing Officer & Franchise Head of Kidney Transplant(age: 39, pay: $668,800)
- Mr. Marcel Konrad Senior Vice President of Fin. and Accounting & Corporation Controller(age: 49, pay: $437,530)
-
How many employees does CareDx have?
As Jul 2024, CareDx employs 635 workers.
-
When CareDx went public?
CareDx, Inc is publicly traded company for more then 11 years since IPO on 17 Jul 2014.
-
What is CareDx's official website?
The official website for CareDx is caredx.com.
-
Where are CareDx's headquarters?
CareDx is headquartered at 1 Tower Place, South San Francisco, CA.
-
How can i contact CareDx?
CareDx's mailing address is 1 Tower Place, South San Francisco, CA and company can be reached via phone at +41 52872300.
-
What is CareDx stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for CareDx in the last 12 months, the avarage price target is $36.75. The average price target represents a 217.35% change from the last price of $11.58.
CareDx company profile:
CareDx, Inc
caredx.comExchange:
NASDAQ
Full time employees:
635
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
1 Tower Place
South San Francisco, CA 94080
South San Francisco, CA 94080
CIK: 0001217234
ISIN: US14167L1035
CUSIP: 14167L103
